Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Authors
Daniel Zips (ORCID: https://orcid.org/0000-0001-5779-9675)
Michael Bitzer
Alfred Königsrainer (ORCID: https://orcid.org/0000-0002-2301-4080)
Medizinischen Fakultät, Eberhard Karls Universität Tübingen
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Daniel Zips, Michael Bitzer, Alfred Königsrainer, Claus Rödel et al.
Citations
20 citations
Journal
The Lancet. Gastroenterology & hepatology
Topics
Colorectal Cancer Surgical Treatments
Field-Weighted Citation Impact (FWCI)
20.91
article
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Daniel Zips, Michael Bitzer, Alfred Königsrainer, Claus Rödel, Elisabeth Germer, Emmanouil Fokas, Oliver Josef Ott, Bülent Polat, Cihan Gani, Rüdiger Hoffmann, Peter Martus, Ralf‐Dieter Hofheinz, Martín Götz, Ulrich Grosse, Markus Diefenhardt, Stephan Clasen, Andreas Kirschniak, Simon Böke, Dörte Wichmann, Rainer Fietkau, Robert Bachmann, Christoph-Thomas Germer
Heidelberg University (DE), University Hospital Heidelberg (DE), Kliniken Maria Hilf (DE), University Children's Hospital Tübingen (DE), Universitätsklinikum Würzburg (DE), Kreiskliniken Reutlingen (DE), University Medical Centre Mannheim (DE), Kantonsspital Frauenfeld (CH), Reutlingen University (DE), University of Tübingen (DE)
Funders
Eberhard Karls Universität Tübingen, Medizinischen Fakultät, Eberhard Karls Universität Tübingen